Agilent 2100 Bioanalyzer

Agilent 2100 Bioanalyzer

The Agilent 2100 Bioanalyzer system is an established automated electrophoresis solution for the quality control of biomolecule samples. The system integrates an instrument, data processing software, reagents, and a microfluidic chip specific for DNA, RNA or protein analysis. It is suitable for diverse next-generation sequencing (NGS), gene expression, biopharmaceutical, and genome editing workflows. Advantages of microfluidics-based automated electrophoresis over traditional gel electrophoresis include dramatically reduced sample (1 µL for nucleic acids, 4 µL for proteins) and reagent consumption, significantly faster analysis time, and less hands-on activities during sample preparation and data analysis. The Agilent 2100 Bioanalyzer system is ideal for moderately low throughput needs (10-12 samples per run).

Manufacturer: Agient
Equipment Rates & Fees
Each chip runs 10 to 12 samples and requires 1ul nucleic acid per sample.
Service Unit RPI User External Nonprofit External Industry External Industry Partner
Bioanalyzer QC per chip $56 $92 $184 $166
  RPI Users External Nonprofit External Industry External Industry Partners
Personnel Time $60 $99 $197 $178

Valid through July 31, 2022. Rates are hourly unless specified otherwise and are subject to change without further notice.

Required Acknowledgement and Authorship

Please acknowledge the CBIS Core Facilities in all publications and grant applications where our equipment and/or personnel have facilitated the work. These acknowledgements are very important because documenting our contributions helps to ensure that the resources of the Core Facilities are sustainable.

  • Equipment: If you used Core Facility equipment, please note this in the Materials and Methods. e.g., Thermogravimetric analysis was carried out using a TA Instruments TGA-Q50 (Rensselaer CBIS Analytical Biochemistry Core Facility).
  • Personnel: Please consider including CBIS personnel as co-authors on your publications when they have made a significant intellectual contribution to the research. Include CBIS Core Facility directors or staff as co-PI or co-investigators in grant applications when they provide a significant contribution to the grant proposal and scientific/intellectual leadership for the proposed work. Please follow these guidelines: ABRF Recommended Guidelines for Authorship on Manuscripts. Also, our Core Facility personnel always appreciate when they are mentioned in the Acknowledgements section of publications.
  • Required Funding Authorization Form: Rensselaer researchers must fill out the CBIS Cores Authorization Form (PDF) to use the CBIS Core Facilities.
Back to top